Cryoablation, Radiofrequency Ablation, and Laser Ablation for Treatment of Chronic Rhinitis
Customize your policy alerts
Sign up for all Blue Cross Blue Shield - Rhode Island policy alerts
Know when Blue Cross Blue Shield - Rhode Island releases new policies or updates existing guidance.
Monitor payer policy activity
Defines coverage and medical necessity stance for cryoablation, radiofrequency ablation, and laser ablation to treat chronic (allergic or nonallergic) rhinitis for Blue Cross Blue Shield - Rhode Island members.
No material clinical or coverage changes in this revision.
Coverage Determination and Criteria
Coverage determination
Coverage stance differs by product:
Benefits for Blue Cross Blue Shield of Rhode Island members may differ by group and contract. Providers should consult the member's Benefit Booklet, Evidence of Coverage, or Subscriber Agreement to confirm whether services described in this policy are covered for a specific member.
For Commercial products, cryoablation, radiofrequency ablation, and laser ablation for chronic rhinitis (allergic or nonallergic) is considered not medically necessary because the evidence is insufficient to determine the effects of these technologies on health outcomes.
Procedure and Diagnosis Codes
| C9771 | Nasal/sinus endoscopy, cryoablation nasal tissue(s) and/or nerve(s), unilateral or bilateral |
| J30.0 | Vasomotor rhinitis |
| J30.1 | Allergic rhinitis due to pollen |
| J30.2 | Other seasonal allergic rhinitis |
| J30.5 | Allergic rhinitis due to food |
| J30.81 | Allergic rhinitis due to animal (cat) (dog) hair and dander |
| J30.89 | Other allergic rhinitis |
| J30.9 | Allergic rhinitis, unspecified |
| J31.0 | Chronic rhinitis |
Provider Requirements and Billing Actions
Prior authorization — Prior authorization is not applicable per policy
Not applicable per policy. Claims billed with the codes listed in the coding section may still be reviewed and processed according to the member’s benefits and contract terms.
- Codes listed under Coding may be subject to review
Conservative therapy expectation — Medical management is expected prior to ablation
Medical management is the standard of care and should be attempted before considering ablation therapies for chronic rhinitis. Ablation therapies (cryoablation, radiofrequency ablation, laser ablation) are proposed alternatives to medical management but are not established as superior.
- Attempt and document appropriate medical therapy prior to any procedural consideration
- Include patient-reported symptom measures and treatment response assessments in the record
Benefit verification — Verify member benefits and eligibility
Benefits and coverage vary by contract. Providers must verify eligibility and specific member benefits prior to providing services. The member’s Benefit Booklet, Evidence of Coverage, or Subscriber Agreement governs coverage and supersedes this policy.
- Contact the provider call center or refer to the member’s benefit documents for plan-specific coverage and eligibility information
- Do not rely solely on this policy to determine member financial responsibility
Denial triggers — Services may be denied as not covered or not medically necessary
Cryoablation, radiofrequency ablation and laser ablation for chronic rhinitis are not covered for Medicare Advantage and are considered not medically necessary for Commercial products; claims may be denied when billed for these indications.
- Affected code: C9771 Nasal/sinus endoscopy, cryoablation nasal tissue(s) and/or nerve(s), unilateral or bilateral
- These services are not supported by sufficient evidence for improvement in health outcomes
Background and Rationale
Ablation therapies—including cryoablation, radiofrequency ablation, and laser ablation—have been proposed as less invasive alternatives to traditional surgical procedures for patients with chronic rhinitis. These procedures aim to reduce autonomic-mediated nasal hyperreactivity by targeting neural input to the nasal mucosa. Clinical management continues to emphasize medical therapy as the standard initial approach, and coverage determinations vary by product due to limited evidence on long-term health outcomes.
Definitions and Devices
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.